Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07044570 · ClinicalTrials.gov registry record

eMOTION: Examining Implicit Attitudes in Physical Activity Engagement

A clinical trial of Cancer and Physical Activity, sponsored by University of Southern California.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT07044570: Recruiting study of Cancer and Physical Activity, sponsored by University of Southern California.

NCT07044570 is a study of Cancer and Physical Activity that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 120 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07044570, a study of Cancer and Physical Activity, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

This early-phase trial will test intervention strategies to influence implicit attitudes towards physical activity and determine whether changes in those mechanisms result in change in physical activity behavior among inactive adults who are overweight or obese.

Primary Outcome

The single-category Implicit Association Test (IAT) will ask participants to match to a conceptual target such as sedentary behavior (e.g., sitting, lying) or physical activity (e.g., walking, running) to affective attributes (e.g., good/bad).If the participant has a strong automatic association between the attribute and conceptual target, then the reaction time will be shorter (representing a favorable implicit attitude). A real-time audibly prompted IAT will be triggered on participants' smart

Interventions

  • BEHAVIORAL Physical Activity Goals mHealth Intervention
  • BEHAVIORAL TYPE/CONTEXT enhancement
  • BEHAVIORAL SAVOR enhancement

Study Locations (1)

California

  • Univeristy of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-03-24
Est. Completion 2026-06-30
University of Southern California

617 total trials

What NCT07044570 shows while recruiting

NCT07044570 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Physical Activity Goals mHealth Intervention is the first listed.

NCT07044570 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07044570 about?

NCT07044570 is a clinical study titled "eMOTION: Examining Implicit Attitudes in Physical Activity Engagement". This early-phase trial will test intervention strategies to influence implicit attitudes towards physical activity and determine whether changes in those mechanisms result in change in physical activity behavior among inactive adults who are overweight or obese.

What is the current status of trial NCT07044570?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-03-24. Estimated completion is 2026-06-30.

What conditions does trial NCT07044570 study?

This clinical trial studies the following conditions: Cancer, Physical Activity, Overweight or Obesity.

What interventions are being tested in trial NCT07044570?

The interventions under investigation include: Physical Activity Goals mHealth Intervention (BEHAVIORAL), TYPE/CONTEXT enhancement (BEHAVIORAL), SAVOR enhancement (BEHAVIORAL).

Who is sponsoring clinical trial NCT07044570?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07044570 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07044570's enrollment target sits among peer trials

120 288th of 615 higher than 321 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07044570, the US trial registry maintained by the National Library of Medicine. NCT07044570 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.